REVELATION BIOSCIENCES, INC. Capital Expenditures
REVELATION BIOSCIENCES, INC. (REVB) reported Capital Expenditures of $111.51 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- REVELATION BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $39.63K.
- REVELATION BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $71.88K.
- REVELATION BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was -$17.69K.
- REVELATION BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $17.69K.
- REVELATION BIOSCIENCES, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $19.17K.
- REVELATION BIOSCIENCES, INC. payments to acquire property, plant, and equipment for fiscal 2021 was $131.96K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $39.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $111.51K 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $71.88K 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | -$17.69K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.00 derived: sum of 2 quarters · filed 2026-02-26 | -$1.00 derived: sum of 3 quarters · filed 2026-02-26 | $19.17K 10-K · filed 2026-02-26 |
| 2024-09-30 | $17.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $17.69K derived: sum of 2 quarters · filed 2025-11-06 | $36.86K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $19.17K 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $19.17K 10-Q · filed 2025-05-08 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-09-23 | $0.00 10-Q/A · filed 2024-09-23 | ||
| 2023-03-31 | $0.00 10-Q/A · filed 2024-09-23 | |||
| 2021-12-31 | -$16.15K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$16.15K derived: sum of 2 quarters · filed 2023-03-30 | $32.86K derived: sum of 3 quarters · filed 2023-03-30 | $131.96K 10-K · filed 2023-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $49.02K derived: sum of 2 quarters · filed 2022-11-10 | $148.12K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $49.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $148.12K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $99.10K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |